[1]
Khasanova, M. et Khakimova, M. 2025. THE ROLE OF ROSUVASTATIN AND EZETIMIBE IN REDUCING MYOCARDIAL INFARCTION RISK. International Conference on Science, Education & Law. 1, 1 (oct. 2025), 244–246. DOI:https://doi.org/10.5281/zenodo.17383649.